SchrageBBurkhoffDRübsamenN, et al.Unloading of the left ventricle during venoarterial extracorporeal membrane oxygenation therapy in cardiogenic shock. JACC Heart Fail2018; 6: 1035–1043.
2.
IannacconeMAlbaniSGianniniF, et al.Short term outcomes of Impella in cardiogenic shock: a review and meta-analysis of observational studies. Int J Cardiol2021; 324: 44–51.
3.
ModiSPHongYSickeMM, et al.Concomitant use of extracorporeal membrane oxygenation and percutaneous microaxial assist device support for cardiogenic shock. JTCVS Open2024; 17: 152–161.
4.
PatelSMLipinskiJAl-KindiSG, et al.Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with Impella is associated with improved outcomes in refractory cardiogenic shock. ASAIO J2019; 65: 21–28.
5.
UnokiTNakayamaTTsurusakiY, et al.Combined use of VA-ECMO and Impella (ECPELLA) improves short- and long-term mortality in patients with cardiogenic shock who received VA-ECMO. Eur Heart J44, Epub ahead of print 2023. DOI: https://doi.org/10.1093/eurheartj/ehad655.1596.
6.
ThieleHMøllerJEHenriquesJPS, et al.Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-up. Lancet2024; 404: 1019–1028.
